Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERN

Pozycja w akcjach #3572
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Cena akcji
$52.95
Ostatnia synchronizacja: 2026-05-15
Kapitalizacja rynkowa
$4.77B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
529.61%
Kraj
US
Handel Terns Pharmaceuticals, Inc. (TERN)

Kategoria

Healthcare
Historia podziałów akcji dla Terns Pharmaceuticals, Inc. (TERN)
Akcje Terns Pharmaceuticals, Inc. (symbol: TERN) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Oct 20, 2026.
Jedna akcja TERN kupiona przed Oct 20, 2026 odpowiada dziś 0 akcjom TERN.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL